Diseases of the Retina Practice Questions

Q: Which imaging modality is best for evaluating retinoblastoma?

CT scan and MRI. **Explanation:** The evaluation of **Retinoblastoma (RB)**, the most common primary intraocular malignancy in children, requires a multi-modal imaging approach to confirm the diagnosis and assess for extraocular spread. **Why "CT scan and MRI" is the correct answer:** * **CT Scan:** This is the gold standard for detecting **intraocular calcification**, which is a hallmark feature of retinoblastoma (present in over 90% of cases). It helps differentiate RB from other "pseudogliomas" like Coats' disease. * **MRI:** This is the superior modality for evaluating **extraocular extension**. It is essential for assessing optic nerve involvement, subarachnoid spread, and intracranial tumors (e.g., Trilateral Retinoblastoma involving the pineal gland). Unlike CT, MRI does not involve ionizing radiation, which is a significant concern in children with the *RB1* mutation who are predisposed to secondary cancers. **Analysis of Incorrect Options:** * **A. Ultrasonography:** While useful for initial screening and detecting calcification (showing high-intensity echoes with acoustic shadowing), it lacks the resolution to evaluate intracranial extension. * **B & D. CT or MRI alone:** While both are vital, neither is sufficient on its own for a complete workup. CT is best for the "bone-like" density of calcification, while MRI is best for soft tissue and neural involvement. **Clinical Pearls for NEET-PG:** * **Most common presentation:** Leukocoria (white pupillary reflex), followed by strabismus. * **Pathology:** Look for **Flexner-Wintersteiner rosettes** (highly specific). * **Trilateral Retinoblastoma:** Bilateral RB associated with a pineal gland tumor (Pineoblastoma). * **Management:** Small tumors are treated with cryotherapy/laser; large tumors with chemoreduction; and advanced cases with enucleation.

Q: In cystoid macular edema, what is the basic defect?

Breakdown of inner blood retinal barrier. **Explanation:** Cystoid Macular Edema (CME) is characterized by the accumulation of fluid in the outer plexiform (Henle’s layer) and inner nuclear layers of the retina, leading to the formation of cystic spaces. **1. Why Option A is Correct:** The fundamental defect in CME is the **breakdown of the inner blood-retinal barrier (BRB)**. The inner BRB is composed of **tight junctions between retinal vascular endothelial cells**. When these junctions are compromised (due to inflammation, traction, or ischemia), fluid leaks from the retinal capillaries into the extracellular space of the macula. **2. Why Other Options are Incorrect:** * **Option B:** The outer BRB consists of the **Retinal Pigment Epithelium (RPE)**. While its dysfunction can lead to subretinal fluid (as seen in Central Serous Chorioretinopathy), the classic "cystoid" pattern of intraretinal fluid is primarily a result of inner BRB failure. * **Option C:** Increased permeability of the choriocapillaris is associated with pachychoroid diseases and exudative age-related macular degeneration, but it is not the primary mechanism for the intraretinal cystic changes seen in CME. **Clinical Pearls for NEET-PG:** * **Pathognomonic Appearance:** On Fundus Fluorescein Angiography (FFA), CME shows a characteristic **"Flower-petal" appearance** (Petaloid pattern) due to the radial arrangement of Henle’s layer. * **Irvine-Gass Syndrome:** This refers to CME occurring specifically after cataract surgery (typically 4–6 weeks post-op). * **Common Causes:** Diabetes (DME), Retinal Vein Occlusion (RVO), Uveitis, and certain drugs (e.g., Prostaglandin analogues, Epinephrine). * **Gold Standard Diagnosis:** **Optical Coherence Tomography (OCT)** is now the preferred non-invasive method to visualize cystic spaces and measure retinal thickness.

Q: What is the most constant and critical finding in retinitis pigmentosa?

Significantly reduced electroretinogram (ERG). **Explanation:** Retinitis Pigmentosa (RP) is a hereditary dystrophy primarily affecting the rod photoreceptors. The diagnosis and monitoring of RP rely on identifying functional deficits of the retina. **Why Option B is Correct:** A **significantly reduced or extinguished Electroretinogram (ERG)** is the most constant, objective, and critical finding. In RP, the ERG (specifically the scotopic/rod response) becomes subnormal or non-recordable very early in the disease, often **before** visible fundus changes or subjective symptoms appear. It is considered the "gold standard" for diagnosis. **Analysis of Incorrect Options:** * **A. Bone spicule pigmentation:** While a classic hallmark, it is **not constant**. In "Retinitis Pigmentosa Sine Pigmento," patients exhibit all functional features of RP but lack visible pigmentary changes. * **C. Tubular visual fields:** This is a late-stage clinical manifestation. Early visual field defects typically present as an equatorial ring scotoma that gradually expands. * **D. Abnormality in the rhodopsin gene:** While the rhodopsin gene (RHO) is commonly mutated in autosomal dominant RP, it is not the only cause. RP is genetically heterogeneous, involving over 100 different genes (e.g., USH2A, RPGR). **High-Yield Clinical Pearls for NEET-PG:** * **Clinical Triad:** Arteriolar attenuation (earliest sign), Bone-spicule pigmentation, and Waxy pallor of the optic disc. * **Earliest Symptom:** Nyctalopia (Night blindness). * **Inheritance:** Most common is Autosomal Recessive; Most severe is X-linked. * **Associated Ocular Findings:** Posterior subcapsular cataract (PSC) and Cystoid Macular Edema (CME). * **EOG (Electro-oculogram):** Also abnormal (Arden index < 1.5), but ERG is more specific for early diagnosis.

Q: Which disease, caused by a mutation in the BEST1 (VMD2) gene, is best diagnosed by a pathological test?

EOG. **Explanation:** The question refers to **Best Vitelliform Macular Dystrophy (Best Disease)**, an autosomal dominant condition caused by a mutation in the **BEST1 (VMD2) gene**. This gene encodes **bestrophin-1**, a protein located in the basolateral membrane of the Retinal Pigment Epithelium (RPE) that functions as a chloride channel. **Why EOG is the Correct Answer:** The hallmark of Best Disease is a generalized dysfunction of the RPE. The **Electro-oculogram (EOG)** measures the standing potential between the front and back of the eye, which is generated by the RPE. In Best Disease, the EOG is **markedly abnormal** (showing a decreased **Arden Index < 1.5**) even in the early stages or in asymptomatic carriers with a normal fundus. This makes it the definitive diagnostic test. **Why Other Options are Incorrect:** * **ERG (Electroretinogram):** This measures the electrical response of the outer retina (photoreceptors). In Best Disease, the **ERG remains normal** because the primary defect is in the RPE, not the neurosensory retina. * **Dark Adaptation:** This tests rod function over time in the dark. While it may be affected in diseases like Vitamin A deficiency or Retinitis Pigmentosa, it is not the diagnostic test for BEST1 mutations. * **Ophthalmoscope:** While an ophthalmoscope can visualize the classic "egg-yolk" (vitelliform) lesion, it cannot diagnose the condition in the pre-vitelliform stage or in carriers. The EOG is the "pathological" functional test required for confirmation. **High-Yield Clinical Pearls for NEET-PG:** * **Stages:** Pre-vitelliform → Vitelliform (Egg-yolk) → Pseudohypopyon → Vitelliruptive (Scrambled egg) → Atrophic/Choroidal Neovascularization (CNV). * **Arden Index:** Normal is >1.8; <1.5 is diagnostic for Best Disease. * **Inheritance:** Autosomal Dominant. * **Visual Prognosis:** Usually remains good until the later atrophic or cicatricial stages.

Q: All of the following may be associated with night-blindness except?

Retinitis proliferans. **Explanation:** Night blindness (Nyctalopia) occurs due to the dysfunction of **rod photoreceptors** or structural damage to the peripheral retina and choroid. **Why Retinitis Proliferans is the correct answer:** Retinitis proliferans is a late-stage complication of proliferative vitreoretinopathy or diabetic retinopathy, characterized by the formation of fibrovascular membranes on the retinal surface. It primarily leads to **tractional retinal detachment** and severe vision loss, but it is not a primary cause of night blindness. It affects the retinal architecture globally rather than specifically targeting the rod-mediated scotopic system. **Analysis of other options:** * **Retinitis Pigmentosa:** The classic cause of night blindness. It is a pigmentary retinal dystrophy that primarily destroys rods in the mid-periphery, leading to "ring scotoma" and tunnel vision. * **Retinitis Punctata Albescens:** A variant of RP (stationary or progressive) characterized by multiple white dots scattered across the fundus. It presents with early-onset night blindness. * **Pathological Myopia:** High myopia leads to chorioretinal degeneration and thinning of the peripheral retina. This structural damage impairs rod function, frequently causing night blindness. **High-Yield Clinical Pearls for NEET-PG:** * **Vitamin A Deficiency:** The most common cause of reversible night blindness worldwide. * **Oguchi’s Disease:** A rare autosomal recessive condition causing congenital stationary night blindness, characterized by the **Mizuo-Nakamura phenomenon** (golden-yellow fundus reflex that disappears after dark adaptation). * **Gyrate Atrophy:** An inborn error of ornithine metabolism causing "garland-shaped" chorioretinal atrophy and night blindness. * **Fundus Albipunctatus:** Another "white dot syndrome" causing stationary night blindness, often confused with Retinitis punctata albescens.

Q: What is the best management for an immunocompromised patient with the following fundus findings?

Sulfadiazine plus pyrimethamine. ***Sulfadiazine plus pyrimethamine*** - The fundus findings show **toxoplasma retinochoroiditis** with characteristic **"headlight in fog"** appearance - focal necrotizing lesion with vitreous haze and pigmented scar - This combination provides **synergistic anti-toxoplasma activity** and is the gold standard treatment for ocular toxoplasmosis in immunocompromised patients *Intravitreal steroids* - **Contraindicated in active infectious retinochoroiditis** as steroids can worsen the infection and increase tissue destruction - May be used only **after initiating anti-toxoplasma therapy** to reduce inflammatory response, not as primary treatment *Ganciclovir* - Specific antiviral agent for **CMV retinitis**, which presents with **"cheese and ketchup"** or **"brush fire"** appearance - CMV retinitis shows **hemorrhagic retinal necrosis** without the characteristic vitreous haze seen in toxoplasmosis *Amphotericin-B* - Antifungal agent used for **fungal endophthalmitis** caused by organisms like **Candida** or **Aspergillus** - Fungal retinitis typically shows **white fluffy infiltrates** and **chorioretinal lesions** without the pathognomonic toxoplasma appearance

Q: Which of the following agents is not used in the treatment of Diabetic Macular Edema/Retinopathy?

Tamoxifen. **Explanation:** The correct answer is **Tamoxifen**. In fact, Tamoxifen is not a treatment for Diabetic Retinopathy (DR); rather, it is a known cause of **toxic retinopathy**. Tamoxifen, a selective estrogen receptor modulator (SERM) used in breast cancer, can cause "Tamoxifen Retinopathy," characterized by bilateral, fine, yellow, crystalline deposits in the macula, which may lead to macular edema and decreased vision. **Analysis of Options:** * **Ruboxistaurin (Option A):** This is a specific inhibitor of **Protein Kinase C (PKC-beta)**. PKC activation is a key pathway in the pathogenesis of diabetic microvascular complications. Ruboxistaurin has been studied to reduce the progression of DR and visual loss. * **Pyridazinones (Option B):** These act as **Aldose Reductase Inhibitors (ARIs)**. The polyol pathway (glucose to sorbitol via aldose reductase) is a major contributor to osmotic stress in diabetic retinal cells. * **Benfotiamine (Option C):** A lipid-soluble derivative of Vitamin B1 (Thiamine). It inhibits the formation of **Advanced Glycation End-products (AGEs)** and reduces oxidative stress, thereby protecting the retinal capillaries from hyperglycemic damage. **High-Yield Clinical Pearls for NEET-PG:** 1. **Gold Standard Treatment:** Intravitreal Anti-VEGF (Ranibizumab, Aflibercept) is currently the first-line treatment for clinically significant macular edema (CSME). 2. **Crystalline Retinopathy D/D:** Tamoxifen, Canthaxanthin, Talc (in IV drug users), and Bietti’s Crystalline Dystrophy. 3. **Pathogenesis of DR:** Remember the mnemonic **"PAGE"**—**P**KC activation, **A**GE accumulation, **G**lucose (Polyol) pathway, and **E**xcessive oxidative stress. All options A, B, and C target these specific pathways.

Q: What percentage of retinoblastomas are bilateral?

30%. **Explanation:** Retinoblastoma is the most common primary intraocular malignancy of childhood. Its occurrence is governed by **Knudson’s "Two-Hit" Hypothesis**, which explains the distribution between unilateral and bilateral cases. **1. Why 30% is Correct:** Approximately **25–30%** of retinoblastoma cases are **bilateral**. These cases are almost always **hereditary**, meaning the child has a germline mutation in the *RB1* gene (the "first hit" is present in every cell of the body). Because every retinal cell carries this mutation, there is a high probability that both eyes will undergo a "second hit," leading to bilateral multifocal tumors. **2. Analysis of Incorrect Options:** * **A (10%) & B (20%):** These percentages are too low. While hereditary cases make up about 40% of all cases, not all hereditary cases present bilaterally at the same time; however, the established clinical average for bilateral presentation remains 30%. * **D (50%):** This is too high. The majority of cases (**70%**) are **unilateral**. Most unilateral cases are sporadic (non-hereditary), where both "hits" occur locally within a single retinal cell. **3. High-Yield Clinical Pearls for NEET-PG:** * **Genetics:** *RB1* gene is located on **Chromosome 13q14**. * **Most Common Sign:** **Leukocoria** (Amaurotic cat’s eye reflex), followed by strabismus. * **Pathology:** Look for **Flexner-Wintersteiner rosettes** (highly specific) and Homer-Wright rosettes. * **Calcification:** Intraocular calcification in a child under 3 years is retinoblastoma until proven otherwise (visible on CT/Ultrasound). * **Trilateral Retinoblastoma:** Bilateral retinoblastoma associated with a pinealoblastoma (pineal gland tumor). * **Risk:** Patients with the germline mutation (bilateral cases) have a high risk of secondary non-ocular malignancies, most commonly **Osteosarcoma**.

Q: A lesion is identified in the orbit. What is the most likely diagnosis?

Choroidal melanoma. **Explanation:** The diagnosis of **Choroidal Melanoma** is the most likely among the options when considering adult intraocular tumors that can present as an orbital or intraocular mass. It is the **most common primary intraocular malignancy in adults**. On imaging (like B-scan USG), it typically presents as a dome-shaped or mushroom-shaped (collar-stud) mass with low internal reflectivity and associated serous retinal detachment. **Analysis of Options:** * **A. Choroidal Melanoma (Correct):** It is the most frequent primary malignant tumor of the eye in adults, arising from melanocytes in the uveal tract. * **B. Ocular Retinoblastoma:** While it is the most common intraocular malignancy in **children**, it is extremely rare in adults. It typically presents with leukocoria (white pupillary reflex) and calcification on CT scans. * **C. Foreign Body:** While common in trauma, a foreign body is usually identified by a clear history of injury and specific radiological features (metallic sheen or shadowing), rather than a solid lesion. * **D. Optic Nerve Drusen:** These are hyaline bodies located within the optic nerve head. They are often bilateral and asymptomatic, appearing as "autofluorescent" or calcified spots on imaging, but they do not form a significant orbital mass. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Choroidal Melanoma:** "To Find Small Ocular Melanoma" (**T**hickness >2mm, **F**luid subretinal, **S**ymptoms, **O**range pigment/Lipofuscin, **M**argin near disc). * **Pathology:** Callender classification (Spindle A, Spindle B, and Epithelioid cells). **Epithelioid cells** carry the worst prognosis. * **Metastasis:** The most common site for distant metastasis is the **Liver**. * **Investigation of Choice:** B-Scan Ultrasonography (shows "Choroidal excavation" and "Acoustic shadowing").

Question 1

Which imaging modality is best for evaluating retinoblastoma?

Accepted Answer

CT scan and MRI

Answer

Ultrasonography

Answer

CT scan

Answer

MRI

Question 2

A 75-year-old patient with a 25-year history of diabetes mellitus presented with sudden painless loss of vision. Fundus examination revealed flame-shaped hemorrhages in the retina. What is the probable diagnosis?

Accepted Answer

Retinal detachment

Answer

Central Retinal Artery Occlusion (CRAO)

Answer

Proliferative retinopathy

Answer

Cystoid macular edema

Question 3

In cystoid macular edema, what is the basic defect?

Accepted Answer

Breakdown of inner blood retinal barrier

Answer

Breakdown of outer blood retinal barrier

Answer

Increased permeability of the choriocapillaris

Answer

All of the above

Question 4

What is the most constant and critical finding in retinitis pigmentosa?

Accepted Answer

Significantly reduced electroretinogram (ERG)

Answer

Bone spicule pigmentation in the retina

Answer

Tubular visual fields

Answer

Abnormality in the rhodopsin gene

Question 5

Which disease, caused by a mutation in the BEST1 (VMD2) gene, is best diagnosed by a pathological test?

Accepted Answer

EOG

Answer

ERG

Answer

Dark adaptation

Answer

Ophthoscope

Question 6

All of the following may be associated with night-blindness except?

Accepted Answer

Retinitis proliferans

Answer

Pathological myopia

Answer

Retinitis pigmentosa

Answer

Retinitis punctata albescens

Question 7

What is the best management for an immunocompromised patient with the following fundus findings?

Accepted Answer

Sulfadiazine plus pyrimethamine

Answer

Intravitreal steroids

Answer

Ganciclovir

Answer

Amphotericin-B

Question 8

Which of the following agents is not used in the treatment of Diabetic Macular Edema/Retinopathy?

Accepted Answer

Tamoxifen

Answer

Ruboxistaurin

Answer

Pyridazinones

Answer

Benfotiamine

Question 9

What percentage of retinoblastomas are bilateral?

Accepted Answer

30%

Answer

10%

Answer

20%

Answer

50%

Question 10

A lesion is identified in the orbit. What is the most likely diagnosis?

Accepted Answer

Choroidal melanoma

Answer

Ocular retinoblastoma

Answer

Foreign body in the orbit

Answer

Optic nerve drusen

Diseases of the Retina — MCQs

Diseases of the Retina — MCQs

On this page

Practice by Chapter

Want unlimited practice?